This site requires JavaScript to be enabled to work properly. Please modify your settings or use a different browser to continue

       

You are now leaving GSK’s website

You are now leaving a GSK Website. By clicking this link, you will be taken to a website that is not owned or controlled by GSK, and GSK is not responsible for the content provided on that site

Continue

Go back

Month Names:$MonthNames

Day Names:$dayNameShort

Popup

Filter By
Showing results refined by: All Therapies | All Indications | All Products | All Events

Oct, 2020

Latest updates in UTI

Diagnostic proposals for acute uncomplicated cystitis in women

02 Oct 2020
There is currently no generally accepted strategy for the clinical diagnosis of acute uncomplicated cystitis. This study evaluated the diagnostic value of recently proposed draft guidelines for the clinical diagnosis of this condition by the US FDA and EMA using the previously validated Acute Cystitis Symptom Score (ACSS).
Find out more
Latest updates in UTI

The difference diabetes can make with regard to UTIs

02 Oct 2020
People with diabetes are more prone to UTIs due to immune system and bladder dysfunction than people without diabetes. In light of controversies regarding the incidence, clinical pattern and microbiology of UTIs in diabetes patients, this prospective study sought to compare these aspects of UTI in patients with and without diabetes.
Find out more
Latest updates in UTI

Appropriateness of fluoroquinolone use in acute uncomplicated cystitis

02 Oct 2020
It is recommended to avoid fluoroquinolones as first-line treatment for uncomplicated cystitis due to the risk of serious side effects but their use in this setting is still widespread. This study evaluated the extent and appropriateness of empiric fluoroquinolone use for uncomplicated cystitis compared with that of nitrofurantoin and identified predictors of empiric fluoroquinolone use for this indication.
Find out more
Latest updates in UTI

Diagnosing and managing UTI in children

02 Oct 2020
UTI is a common infection in children but can be a challenge to diagnose. In addition, controversies exist regarding its investigation and management and recommendations vary across guidelines. This review paper gives an overview of these aspects with highlights from recent evidence and guideline recommendations.
Find out more
Items per Page
5

Displaying Page

Adverse events should be reported. Reporting forms and information can be found at [/home/report-adverse-event.html]

Adverse events should also be reported to GlaxoSmithKline on link